NuGenea™
Meaning ‘New Life’ in Greek, NuGenea is Ludwig’s flagship nutraceutical scientifically formulated to reduce chronic inflammation. Available for purchase now.
mRNA Inflammatory Index™
Patent pending technology that combines gene sequencing microassay and artificial intelligence that measures and monitors 48 different biomarkers of chronic inflammation. Available in Q4 2023.
mResearchRNA™
Precision Genomics, Ludwig Enterprises’ subsidiary, supports the pharmaceutical, biotechnology and clinical research. PG’s extensive patient meta data and mRNA microassay results could potentially be of value during the drug and product development process. PG is developing partnerships for clinical research with universities, clinical research organizations, health systems and healthcare providers.
